271 related articles for article (PubMed ID: 32422339)
21. Advances in pharmacotherapy for the treatment of gout.
Robinson PC; Dalbeth N
Expert Opin Pharmacother; 2015 Mar; 16(4):533-46. PubMed ID: 25547991
[TBL] [Abstract][Full Text] [Related]
22. Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice.
Singh JA; Richards JS; Chang E; Toupin-April K; Barton JL
Clin Rheumatol; 2021 Feb; 40(2):693-700. PubMed ID: 32997317
[TBL] [Abstract][Full Text] [Related]
23. A survey on the management of gout in Malaysia.
Yeap SS; Goh EM; Gun SC
Int J Rheum Dis; 2009 Dec; 12(4):329-35. PubMed ID: 20374371
[TBL] [Abstract][Full Text] [Related]
24. A new perspective on the pharmacoeconomics of colchicine.
Wertheimer AI; Davis MW; Lauterio TJ
Curr Med Res Opin; 2011 May; 27(5):931-7. PubMed ID: 21370937
[TBL] [Abstract][Full Text] [Related]
25. The unwelcome visitor.
Teng GG; Tong CY; How CH; Goh LH
Singapore Med J; 2012 Aug; 53(8):508-11; quiz 512. PubMed ID: 22941126
[TBL] [Abstract][Full Text] [Related]
26. Real-world treatment patterns of gout patients treated with colchicine or other common treatments for gout in acute care settings: a retrospective chart review study.
Shiozawa A; Cloutier M; Heroux J; Guerin A; Wu EQ; Jackson R
Curr Med Res Opin; 2015 Aug; 31(8):1611-20. PubMed ID: 26086788
[TBL] [Abstract][Full Text] [Related]
27. Treatment for acute flares of gout: A protocol for systematic review.
Tang H; Xu G; Zheng Q; Cheng Y; Zheng H; Li J; Yin Z; Liang F; Chen J
Medicine (Baltimore); 2020 Apr; 99(14):e19668. PubMed ID: 32243400
[TBL] [Abstract][Full Text] [Related]
28. [Gout management: an update].
Ankli B; Krähenbühl S
Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
[TBL] [Abstract][Full Text] [Related]
29. Italian Society of Rheumatology recommendations for the management of gout.
Manara M; Bortoluzzi A; Favero M; Prevete I; Scirè CA; Bianchi G; Borghi C; Cimmino MA; D'Avola GM; Desideri G; Di Giacinto G; Govoni M; Grassi W; Lombardi A; Marangella M; Matucci Cerinic M; Medea G; Ramonda R; Spadaro A; Punzi L; Minisola G
Reumatismo; 2013 Mar; 65(1):4-21. PubMed ID: 23550256
[TBL] [Abstract][Full Text] [Related]
30. Gout and its comorbidities: implications for therapy.
Stamp LK; Chapman PT
Rheumatology (Oxford); 2013 Jan; 52(1):34-44. PubMed ID: 22949727
[TBL] [Abstract][Full Text] [Related]
31. Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.
Vargas-Santos AB; Castelar-Pinheiro Gda R; Coutinho ES; Schumacher HR; Singh JA; Schlesinger N
PLoS One; 2015; 10(8):e0135805. PubMed ID: 26274585
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology, clinical presentation and treatment of gout.
Teng GG; Nair R; Saag KG
Drugs; 2006; 66(12):1547-63. PubMed ID: 16956303
[TBL] [Abstract][Full Text] [Related]
33. Management of gout in older adults: barriers to optimal control.
Hoskison KT; Wortmann RL
Drugs Aging; 2007; 24(1):21-36. PubMed ID: 17233545
[TBL] [Abstract][Full Text] [Related]
34. Casebook consults: improving outcomes in gout (multimedia activity).
Doghramji PP; Mandell BF; Pope RS
Am J Med; 2012 Aug; 125(8):S1. PubMed ID: 22840678
[TBL] [Abstract][Full Text] [Related]
35. Colchicine--what is its place in the management of acute gout?
Winzenberg T; Zochling J
Aust Fam Physician; 2007 Jul; 36(7):529-30. PubMed ID: 17619668
[TBL] [Abstract][Full Text] [Related]
36. Risks and benefits of drugs used in the management and prevention of gout.
Conaghan PG; Day RO
Drug Saf; 1994 Oct; 11(4):252-8. PubMed ID: 7848545
[TBL] [Abstract][Full Text] [Related]
37. Management of gout in the older adult.
Fravel MA; Ernst ME
Am J Geriatr Pharmacother; 2011 Oct; 9(5):271-85. PubMed ID: 21849262
[TBL] [Abstract][Full Text] [Related]
38. Diversity of opinions on the management of gout in France. A survey of 750 rheumatologists.
Rozenberg S; Lang T; Laatar A; Koeger AC; Orcel P; Bourgerois P
Rev Rhum Engl Ed; 1996 Apr; 63(4):255-61. PubMed ID: 8738444
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.
Wechalekar MD; Vinik O; Moi JH; Sivera F; van Echteld IA; van Durme C; Falzon L; Bombardier C; Carmona L; Aletaha D; Landewé RB; van der Heijde DM; Buchbinder R
J Rheumatol Suppl; 2014 Sep; 92():15-25. PubMed ID: 25180124
[TBL] [Abstract][Full Text] [Related]
40. GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.
Pascart T; Lancrenon S; Lanz S; Delva C; Guggenbuhl P; Lambert C; Aubert JP; Saraux A; Ea HK; Lioté F
Joint Bone Spine; 2016 Dec; 83(6):687-693. PubMed ID: 26919801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
